The state of gonadotropic and prolactin-synthesizing function of the pituitary gland in adolescent girls with oligomenorrhea depending on the disease duration
DOI:
https://doi.org/10.18370/2309-4117.2024.74.25-30Keywords:
oligomenorrhea, adolescents, gonadotropins, prolactinAbstract
Objective of the study: to find out the characteristics of the content of gonadotropins (luteinizing (LH) and follicle-stimulating (FSH) hormones)and prolactin (PRL) at different duration of oligomenorrhea (OM) in adolescent girls.
Materials and methods. A general clinical examination, laboratory study of gonadotropins, PRL, carbohydrate metabolism was conducted in 194 adolescent girls aged 12–18 years with OM. The control group included 30 adolescent girls without OM.
Results. The average content of gonadotropins had significant differences with the control group and in comparing the groups with each other. The mean LH values were significantly higher compared to the control group. The duration of OM had a negative effect on the LH level. LH value was increased by almost 3 times during the OM prolongation. PRL value significantly increased in girls with the existence of OM for more than 2 years. Almost 23% of patients had deviations in the content of PRL, both in the direction of increase and decrease. FSH, on the contrary, mostly fluctuated within physiological values. An increase LH/FSH ratio was registered in every fourth girl with OM at the beginning of the disease. Number of girls with high values of this ratio increased by 1.5–1.6 times.
OM is characterized by dysgonadotropinemia. It was found in more than half of the patients (53.5%). Normogonadotropinemia was registered in a less than a third of patients (26.3%). Every fifth to sixth girl had hypergonadotropinemia (both gonadotropin hormones are elevated). Hypogonadrtropinemia (both gonadotropin hormones are decreased) was noted in isolated cases. The most frequent variants of dysgonadotropinemia were a combination of high LH and normative FSH, or normative LH and reduced FSH. That is, a relative deficiency of FSH is formed.
Conclusions. The most important cause of OM is a violation of hormonal relationships. An increase in the levels of LH and PRL with the extension of the OM duration increases the risk of polycystic ovary syndrome. Regardless of FSH fluctuations, mainly within reference values, a relative FSH insufficiency is formed. Even reduced PRL leads to the metabolic disorders.
References
- Cheng TS, Ong KK, Biro FM. Adverse effects of early puberty timing in girls and potential solutions. J Pediatr Adolesc Gynecol. 2022 Oct;35(5):532–5. DOI: 10.1016/j.jpag.2022.05.005.
- Le-Ha C, Beilin LJ, Burrows S, et al. Age at menarche and childhood body mass index as predictors of cardio-metabolic risk in young adulthood: A prospective cohort study. PLoS One. 2018 Dec 21;13(12):e0209355. DOI: 10.1371/journal.pone.0209355.
- Steppan M, Whitehead R, McEachran J, et al. Family composition and age at menarche: Findings from the international Health Behaviour in School-aged Children study. Reprod Health. 2019;16(1):176. DOI: 10.1186/s12978-019-0822-6.
- Khan L. Puberty: Onset and Progression. Pediatr Ann. 2019 Apr 1;48(4):e141–e145. DOI: 10.1186/s12978-019-0822-6.
- Breehl L, Caban O. Physiology, Puberty. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih. gov/books/NBK534827/.
- Sopher AB, Oberfield SE, Witchel SF. Disorders of puberty in girls. Semin Reprod Med. 2022 Mar;40(1-02):3–15. DOI: 10.1055/s-0041-1735892.
- Anikwe CC, Mamah JE, Okorochukwu BC, et al. Age at menarche, menstrual characteristics, and its associated morbidities among secondary school students in Abakaliki, southeast Nigeria. Heliyon. 2020 May 26;6(5):e04018. DOI: 10.1016/j.heliyon.2020.e04018.
- Itriyeva K. The normal menstrual cycle. Curr Probl Pediatr Adolesc Health Care. 2022 May;52(5):101183. DOI: 10.1016/j.cppeds.2022.101183.
- Naz MSG, Farahmand M, Dashti S, Tehrani FR. Factors Affecting Menstrual Cycle Developmental Trajectory in Adolescents: A Narrative Review. Int J Endocrinol Metab. 2022 Mar 2;20(1):e120438. DOI: 10.5812/ijem.120438.
- Ashurova NG, Jumaeva MM. Risk factors promoting the formation of disorders of the menstrual cycle in teenage girls. Literature Review [Internet]. Annals of the romanian society for cell biology. 2021 Apr.10; 25(4): 1881-1886. Available from: http://annalsofrscb.ro/index.php/journal/article/view/2710.
- Gruber N, Modan-Moses D. Menstrual cycle in adolescents: updating the normal pattern. J Clin Endocrinol Metab. 2021 Jan 1;106(1):e372–e374. DOI: 10.1210/clinem/dgaa688.
- Vollmar AKR, Mahalingaiah S, Jukic AM. The Menstrual Cycle as a Vital Sign: A Comprehensive Review. 2024: 2024070965. DOI: 10.20944/preprints202407.0965.v1.
- Abbasi S, Naz S, Khalid S, et al. Menstrual Pattern and Common Menstrual Disorders among Adolescent Girls. Pakistan Journal of Medical & Health Sciences. 2022.16(06):1031. DOI: 10.53350/pjmhs221661031
- Gumeniuk O, Chernenkov Y, Ribakova I, et al. Endocrine and menstrual disorders in adolescent girls: clinical parallels. Endocrine Abstracts. Bioscientifica. 2019.63:326. DOI: 10.1530/endoabs.63.P326.
- Gandotra N, Mahajan N. To study the menstrual pattern and various menstrual problems among adolescent girls. International Journal of Clinical Obstetrics and Gynaecology.2020.4(4): 227-9. DOI: 10.33545/gynae.2020.v4.i4d.650.
- Choudhary A, Nair P, Jungari M, et al. Adolescent Clinic—Need of the Era. Biosc. Biotech. Res. Comm. 2021 Jun18;14(06):41-4. DOI: 10.21786/bbrc/14.6.9.
- Zhou X, Yang X. Association between obesity and oligomenorrhea or irregular menstruation in Chinese women of childbearing age: a cross-sectional study. Gynecol Endocrinol. 2020 Dec;36(12):1101-05. DOI: 10.1080/09513590.2020.1803823.
- Krüger THC, Leeners B, Tronci E, et al. The androgen system across the menstrual cycle: Hormonal, (epi-)genetic and psychometric alterations. Physiol Behav. 2023 Feb 1;259:114034. DOI: 10.1016/j.physbeh.2022.114034
- Auriemma RS, Scairati R, Pirchio R, et al. Cardiometabolic effects of hypoprolactinemia. Rev Endocr Metab Disord. 2024 Jul 30. Available from: DOI: 10.1007/s11154-024-09891-z.
- Pirchio R, Graziadio C, Colao A, et al. Metabolic effects of prolactin. Front Endocrinol (Lausanne). 2022 Sep 27;13:1015520. DOI: 10.3389/fendo.2022.1015520.
- Macotela Y, Triebel J, Clapp C. Time for a new perspective on prolactin in metabolism. Trends Endocrinol Metab. 2020 Apr;31(4):276-286. DOI: 10.1016/j.tem.2020.01.004
- Atıcı ÖK, Govindrajan N, Lopetegui-González I, et al. Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis. Semin Cell Dev Biol. 2021 Jun;114:159-170. DOI: 10.1016/j.semcdb.2020.10.005.
- Selzer C, Ott J, Dewailly D, et al. Prolactin levels in functional hypothalamic amenorrhea: a retrospective case-control study. Arch Gynecol Obstet. 2024 Feb;309(2):651-8. DOI: 10.1007/s00404-023-07277-1.
- Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1071–e1083. DOI: 10.1210/clinem/dgaa839
- Macotela Y, Ruiz-Herrera X, Vázquez-Carrillo DI, et al. The beneficial metabolic actions of prolactin. Front Endocrinol (Lausanne). 2022 Sep 23;13:1001703. DOI: 10.3389/fendo.2022.1001703.
- Ponce AJ, Galván-Salas T, Lerma-Alvarado RM, et al. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine. 2020 Feb;67(2):331–43. DOI: 10.1007/s12020-019-02170-x
- Moretti C. Menstrual Disorders Related to Endocrine Diseases. In: Petraglia F, Fauser B. (eds) Female Reproductive Dysfunction. [Internet]. Endocrinology. Springer, Cham. 2020. Available from: https://link.springer.com/reference workentry/10.1007/978-3-030-14782-2_4
- Casas RS, Chuang CH. Menstruation and Secondary Amenorrhea. In: Tilstra SA, Kwolek D, Mitchell JL, Dolan BM, Carson MP (eds) Sex- and Gender-Based Women’s Health. [Internet]. Springer, Cham. 2020. Available from: https://link.springer.com/ch apter/10.1007/978-3-030-50695-7_5.
- Itriyeva K. The effects of obesity on the menstrual cycle. Curr Probl Pediatr Adolesc Health Care. 2022 Aug;52(8):101241. DOI: 10.1016/j.cppeds.2022.101241
- Levine S, Muneyyirci-Delale O. Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach. Obstet Gynecol Int. 2018 Dec 3;2018:9253083. DOI: 10.1155/2018/9253083
- Almazrouei R, Zaman S, Wernig F, et al. Utility of cannulated prolactin to exclude stress hyperprolactinemia in patients with persistent mild hyperprolactinemia. Clin Med Insights Endocrinol Diabetes. 2021 Jun 22;14:11795514211025276. DOI: 10.1177/11795514211025276.
- Saei Ghare Naz M, Dovom MR, Tehrani FR. The Menstrual Disturbances in Endocrine Disorders: A Narrative Review. Int J Endocrinol Metab. 2020 Oct 14;18(4):e106694. DOI: 10.5812/ijem.106694.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.